Literature DB >> 23664172

Prognosis of secondary acute myeloid leukemia.

Matteo Giovanni Della Porta.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23664172     DOI： 10.1016/j.leukres.2013.04.016

Source DB:  PubMed          Journal:  Leuk Res        ISSN： 0145-2126            Impact factor:   3.156


× No keyword cloud information.
  3 in total

1.  Comparable outcomes post allogeneic hematopoietic cell transplant for patients with de novo or secondary acute myeloid leukemia in first remission.

Authors:  F V Michelis; E G Atenafu; V Gupta; D D Kim; J Kuruvilla; J H Lipton; D Loach; M D Seftel; J Uhm; N Alam; A Lambie; L McGillis; H A Messner
Journal:  Bone Marrow Transplant       Date:  2015-03-30       Impact factor: 5.483

2.  Impact of conditioning regimen intensity on outcomes of second allogeneic hematopoietic cell transplantation for secondary acute myelogenous leukemia.

Authors:  Arnon Nagler; Christophe Peczynski; Bhagirathbhai Dholaria; Myriam Labopin; Thomas Valerius; Peter Dreger; Nicolaus Kröger; Hans Christian Reinhardt; Jürgen Finke; Georg-Nikolaus Franke; Fabio Ciceri; Mareike Verbeek; Igor Wolfgang Blau; Martin Bornhäuser; Alexandros Spyridonidis; Gesine Bug; Ali Bazarbachi; Christophe Schmid; Ibrahim Yakoub-Agha; Bipin N Savani; Mohamad Mohty
Journal:  Bone Marrow Transplant       Date:  2022-04-30       Impact factor: 5.174

3.  BMI1 reprogrammes histone acetylation and enhances c-fos pathway via directly binding to Zmym3 in malignant myeloid progression.

Authors:  Hongjie Shen; Zixing Chen; Xin Ding; Xiaofei Qi; Jiannong Cen; Yuanyuan Wang; Li Yao; Yan Chen
Journal:  J Cell Mol Med       Date:  2014-02-27       Impact factor: 5.310
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.